Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Vir Biotechnology, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $100 Billion
- Q4 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 35,081 shares of VIR stock, worth $220,659. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,081
Previous 25,770
36.13%
Holding current value
$220,659
Previous $193,000
33.16%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding VIR
# of Institutions
234Shares Held
90MCall Options Held
1.28MPut Options Held
235K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$105 Million1.08% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$103 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$82.6 Million0.0% of portfolio
-
State Street Corp Boston, MA5.07MShares$31.9 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.22MShares$20.2 Million0.64% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $834M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...